The effect of treatment with montelukast on in vitro interleukin‐10 production of mononuclear cells of children with asthma
- 21 February 2005
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 35 (2) , 213-220
Abstract
Summary: Background The effects of leukotriene modifiers on IL‐10 production have not been studied in children with asthma.Objective The primary objective of this study was to determine the changes in IL‐10 concentrations, clinical efficacy and peripheral blood eosinophil counts after treatment with montelukast.Methods The study was conducted on 27 patients: 13 patients monoallergic to grass pollen during the pollen season (GPs group) and out of the pollen season (GPos group), and on 14 patients monoallergic to house dust mite (HDM) from May to September (HDM group). Main outcome measures were changes in concentrations of IL‐10 in the supernatant after a 4‐week treatment with montelukast. Measurements of asthma severity score, forced expiratory volume in 1 s (FEV1) and peripheral blood eosinophil counts were the secondary end‐points.Results Montelukast resulted in a within‐group significant increase in IL‐10 concentration in the supernatant in the GPs (54.0 vs. 125.5 pg/mL) and in the HDM (51.2 vs. 77.1 pg/mL) group. Montelukast had no effect on changes of IL‐10 concentration in the supernatant from peripheral blood mononuclear cell (PBMC) culture after non‐sensitizing allergen stimulation. Montelukast significantly improved asthma control and FEV1, and significantly decreased eosinophil blood count in the GPs and in the HDM group after a 4‐week treatment. Montelukast did not lead to changes of all measured parameters within the GPos group.Conclusion Montelukast increased IL‐10 concentration in supernatants from sensitizing allergen‐stimulated PBMC culture obtained from children with asthma monoallergic to grass pollen during the pollen season, and from children with asthma monoallergic to HDM.Keywords
This publication has 29 references indexed in Scilit:
- Allergen‐specific T cells from birch‐pollen‐allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin‐10 productionClinical & Experimental Allergy, 2004
- Increased expression of allergen‐induced in vitro interleukin‐10 and interleukin‐18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapyClinical & Experimental Allergy, 2004
- Allergen-induced cytokine production, atopic disease, IgE, and wheeze in childrenJournal of Allergy and Clinical Immunology, 2003
- Interleukin-10 Therapy—Review of a New ApproachPharmacological Reviews, 2003
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- A randomized, double‐blind trial of the effect of glucocorticoid, antileukotriene and bβ‐agonist treatment on IL‐10 serum levels in children with asthmaClinical & Experimental Allergy, 2002
- Effects of ONO‐1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthmaClinical & Experimental Allergy, 1999
- IL-10: Evolving concepts☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Interleukin-10 regulation in normal subjects and patients with asthmaJournal of Allergy and Clinical Immunology, 1996
- CD40 expression by human peripheral blood eosinophils.Journal of Clinical Investigation, 1996